Drug Shortage Report for RITUXAN SC

Last updated on 2024-12-04 History
Report ID 243448
Drug Identification Number 02457350
Brand name RITUXAN SC
Common or Proper name RITUXIMAB
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) RITUXIMAB
Strength(s) 1400MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 X VIAL
ATC code L01FA
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-11-29
Actual start date 2024-11-29
Estimated end date 2024-12-13
Actual end date 2024-12-03
Shortage status Resolved
Updated date 2024-12-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-12-04 English Compare
v12 2024-12-03 French Compare
v11 2024-12-03 English Compare
v10 2024-12-03 French Compare
v9 2024-12-03 English Compare
v8 2024-12-03 French Compare
v7 2024-12-03 English Compare
v6 2024-12-03 English Compare
v5 2024-11-30 English Compare
v4 2024-11-26 French Compare
v3 2024-11-26 English Compare
v2 2024-11-19 French Compare
v1 2024-11-19 English Compare

Showing 1 to 13 of 13